NuVasive, Inc. (OQ:NUVA)

Business Focus: Medical Equipment, Supplies & Distribution

Nov 30, 2020 07:33 am ET
NuVasive Unveils C360 Portfolio and Launches New Anterior Cervical Plate
SAN DIEGO, Nov. 30, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the unveiling of its new C360™ cervical spine portfolio, including the commercial launch of the Anterior Cervical Plating (ACP) system, featuring the thinnest plate on the market1 at 1.6 mm. ...
Nov 23, 2020 03:03 pm ET
NuVasive to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
SAN DIEGO, Nov. 23, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in one-on-one investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 2-3, 2020. ...
Nov 18, 2020 07:33 am ET
NuVasive Expands Proprietary Porous PEEK Portfolio with Cohere XLIF Interbody
SAN DIEGO, Nov. 18, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Cohere® XLIF®, the first Porous PEEK™ interbody brought to market for use in eXtreme Lateral Interbody Fusion (XLIF) and X360™ surgeries. Cohere XLIF is a key addition to NuVasive's Advanced Materials Science™ (AMS) implant portfolio, consisting of proprietary surface and structural technologies, and is designed for bone in-growth while mai...
Nov 09, 2020 07:33 am ET
NuVasive's Thoracolumbar Interbody Portfolio Receives First Clearance in the US for the Treatment of Sagittal Deformities
SAN DIEGO, Nov. 4, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its thoracolumbar interbody portfolio to include the treatment of multi-level sagittal deformities of the thoracolumbar spine. This clearance expands the portfolio's indications from one- to two-level spine surgery, to now multiple levels, for the treatment of sagittal malalig...
Nov 02, 2020 03:03 pm ET
NuVasive to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference
SAN DIEGO, Nov. 2, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the Credit Suisse 29th Annual Virtual Healthcare Conference on Monday, November 9, 2020 at 11:00 a.m. ET/8:00 a.m. PT.  ...
Oct 29, 2020 04:02 pm ET
NuVasive Announces Third Quarter 2020 Financial Results
SAN DIEGO, Oct. 29, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended September 30, 2020....
Oct 27, 2020 08:33 am ET
NuVasive to Participate as Gold Level Sponsor at SMISS Annual Forum
SAN DIEGO, Oct. 27, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a gold level sponsor at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum held virtually from October 29-31, 2020. NuVasive is also a committed platinum level sponsor of the annual forum for the proceeding three years, to further support the advancement of less invasive spine surgery....
Oct 19, 2020 04:03 pm ET
NuVasive Announces Conference Call and Webcast of Third Quarter 2020 Results
SAN DIEGO, Oct. 19, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its third quarter 2020 earnings results on Thursday, October 29, 2020 after the close of the market....
Oct 14, 2020 04:02 pm ET
NuVasive Announces New Organizational Structure to Align Global Commercial Operations and Product & Services Organization with Long-Term Strategy
SAN DIEGO, Oct. 14, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced a new organizational and leadership structure for its global commercial operations as well as its product and services organization, which were previously consolidated under the role of the Company's president. The changes establish a new global commercial leader and bring together the Company's product and services teams under a single global leader. They...
Aug 04, 2020 04:03 pm ET
NuVasive Announces Second Quarter 2020 Financial Results
SAN DIEGO, Aug. 4, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended June 30, 2020....
Jul 22, 2020 08:33 am ET
NuVasive's Less Invasive Procedural Solutions Are Clinically Proven to Reduce Operative Time and Improve Patient Outcomes in Spine Surgery
SAN DIEGO, July 22, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today launched its Time to Evolve campaign, calling surgeons to reconsider the way patient care is delivered in spine surgery by adopting NuVasive's less invasive approaches, best-in-class training and comprehensive procedural portfolio. ...
Jul 20, 2020 04:05 pm ET
NuVasive Announces Certain Preliminary Unaudited Second Quarter 2020 Results
SAN DIEGO, July 20, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced certain preliminary unaudited results for the second quarter 2020. ...
Jul 17, 2020 08:33 am ET
NuVasive Becomes First Industry Sponsor of the American Spine Registry to Improve Future of Spine Surgery Through Data-Driven Outcomes
SAN DIEGO, July 17, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, and the American Spine Registry™ (ASR), a national quality improvement registry for spine care, today announced that they have entered into a multi-year sponsorship to improve the future of spine surgery through data-driven outcomes. ASR is a collaboration between the American Association of Neurological Surgeons (AANS) and the American Academy of Orthopaedic Surgeons (AAOS) and t...
Jun 18, 2020 08:33 am ET
NuVasive Expands Complex Spine Portfolio with Global Launch of Reline 3D for Pediatric Deformity
SAN DIEGO, June 18, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the expansion of its complex spine portfolio with the global commercial availability of Reline 3D™, a posterior fixation system for patients suffering from pediatric spinal deformities. ...
Jun 05, 2020 10:53 am ET
DLA Piper advises NuVasive in its US$400 million convertible senior notes offering
NEW YORK, June 5, 2020 /PRNewswire/ -- DLA Piper represented advised NuVasive, Inc. (NASDAQ: NUVA), a San Diego-based medical device company that creates and distributes products for surgical treatment of spine disorders, in its offering of US$400 million aggregate principal amount of 1.00% convertible senior notes due 2023. NuVasive also granted to the initial purchasers of the convertible notes a 13-day option to purchase up to an additional US$50 million principal amount of the notes....
Jun 04, 2020 04:10 pm ET
NuVasive, Inc. Announces Full Exercise Of Option By Initial Purchasers To Purchase Additional 1.00% Convertible Senior Notes Due 2023
SAN DIEGO, June 4, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today that it closed the issuance of an additional $50.0 million in aggregate principal amount of the 1.00% Convertible Senior Notes due 2023 (the "Convertible Notes"), pursuant to the exercise in full of the initial purchasers' option to purchase such additional notes (the "Option Notes") in connection with the previously announced Convertible Notes offering that closed on June 1, 2020. ...
May 28, 2020 12:18 am ET
NuVasive, Inc. Announces Pricing Of Offering Of $400 Million Of 1.00% Convertible Senior Notes Due 2023
SAN DIEGO, May 28, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today the pricing of its offering (the "Offering") of $400.0 million aggregate principal amount of 1.00% Convertible Senior Notes due 2023 (the "Convertible Notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). NuVasive also granted to the initial purchasers of the Convertible Notes a 13-day option to purchase up to an additional $50.0 million aggregate principal amount of the Convertible Notes. The sale of the C...
May 26, 2020 04:02 pm ET
NuVasive, Inc. Announces Proposed Offering Of $400 Million Of Convertible Senior Notes Due 2023
SAN DIEGO, May 26, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today that it intends to offer (the "Offering"), subject to market and other considerations, $400.0 million aggregate principal amount of Convertible Senior Notes due 2023 (the "Convertible Notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). NuVasive also intends to grant to the initial purchasers of the Convertible Notes a 13-day option to purchase up to an additional $50.0 million aggregate principal amount o...
May 19, 2020 08:33 am ET
NuVasive LessRay® Platform Wins Best New Imaging Technology Solution in 2020 MedTech Breakthrough Awards
SAN DIEGO, May 19, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRay® radiation reduction and workflow enhancement platform won the "Best New Imaging Technology Solution" award in the 2020 MedTech Breakthrough Awards....
May 12, 2020 04:03 pm ET
NuVasive to Participate in UBS Virtual Global Healthcare Conference
SAN DIEGO, May 12, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the UBS Virtual Global Healthcare Conference on Tuesday, May 19 at 3:00 p.m. ET/12:00 p.m. PT.  ...
May 06, 2020 04:02 pm ET
NuVasive Announces First Quarter 2020 Financial Results
SAN DIEGO, May 6, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended March 31, 2020....
May 05, 2020 08:33 am ET
NuVasive Expands Advanced Materials Science™ Implant Portfolio to Additional Thoracolumbar Procedures
SAN DIEGO, May 5, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the expansion of its Advanced Materials Science™ (AMS) implant portfolio with the commercial launch of the Modulus® XLIF® Dual Sided Plate, and the receipt of 510(k) clearances from the U.S. Food and Drug Administration (FDA) for Modulus ALIF and Cohere® TLIF-O. ...
May 04, 2020 04:03 pm ET
NuVasive to Participate in BofA Securities 2020 Healthcare Conference
SAN DIEGO, May 4, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the virtual BofA Securities 2020 Healthcare Conference on Tuesday, May 12 at 5:00 p.m. ET/2:00 p.m. PT.  ...
Apr 14, 2020 04:02 pm ET
NuVasive Provides Business Update Related to COVID-19
SAN DIEGO, April 14, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today provided an update on actions the Company is taking to best position the business and support the Company's stakeholders in light of the COVID-19 pandemic....
Nov 14, 2019 07:33 am ET
NuVasive to Participate as Double Diamond Sponsor at the 13th International Congress on Early Onset Scoliosis and Host the MAGEC® Users Meeting
SAN DIEGO, Nov. 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will participate as a double diamond sponsor at the 13th International Congress on Early Onset Scoliosis (ICEOS), November 21-22, 2019 at the Westin Peachtree Plaza in Atlanta. At the same location, on November 23, 2019, NuVasive will host the fourth annual MAGEC® Users Meeting....
Nov 13, 2019 07:33 am ET
NuVasive to Participate as Gold Sponsor at the Cervical Spine Research Society 47th Annual Meeting
SAN DIEGO, Nov. 13, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will participate as a gold sponsor at the Cervical Spine Research Society (CSRS) 47th Annual Meeting, November 21-23, 2019 at the New York Marriott Marquis in New York City....
Nov 04, 2019 03:03 pm ET
NuVasive to Present at the 28th Annual Credit Suisse Healthcare Conference
SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the 28th Annual Credit Suisse Healthcare Conference at The Phoenician in Scottsdale, Arizona on Tuesday, November 12, 2019, at 1:50 p.m. MST/ 3:50 p.m. EST. ...
Oct 30, 2019 04:03 pm ET
NuVasive Announces Third Quarter 2019 Financial Results
SAN DIEGO, Oct. 30, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended September 30, 2019....
Oct 14, 2019 04:07 pm ET
NuVasive Announces Conference Call and Webcast of Third Quarter 2019 Results
SAN DIEGO, Oct. 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its third quarter 2019 earnings results on Wednesday, October 30, 2019 after the close of the market....
Oct 09, 2019 08:33 am ET
NuVasive to Participate as Gold Sponsor at the EUROSPINE 2019 Annual Meeting
SAN DIEGO, Oct. 9, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a gold sponsor at the EUROSPINE 2019 Annual Meeting held October 16-18, 2019 in Helsinki, Finland. ...
Sep 25, 2019 08:33 am ET
NuVasive to Demonstrate Enabling Technologies to Accelerate the Adoption of Less Invasive Spine Surgery at NASS 2019
SAN DIEGO, Sept. 25, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will highlight its enabling technologies at the North American Spine Society (NASS) Annual Meeting, September 25-28, 2019 at McCormick Place in Chicago....
Sep 23, 2019 04:03 pm ET
NuVasive LessRay® Platform Wins 2019 Spine Technology Award from Orthopedics This Week
SAN DIEGO, Sept. 23, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRay® radiation reduction and workflow enhancement platform won the 2019 Spine Technology Award presented by Orthopedics This Week, a widely read publication in the orthopedics industry. The Spine Technology Award recognizes the best new spine technologies, engineering teams and inventors for 2019 and rewards excellence in innovation. ...
Sep 11, 2019 08:33 am ET
NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting
SAN DIEGO, Sept. 11, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a double diamond sponsor at the Scoliosis Research Society (SRS) 54th Annual Meeting held September 18-21, 2019 in Montréal, Canada. ...
Sep 05, 2019 08:33 am ET
NuVasive Expands Cervical Advanced Materials Science™ Portfolio with Launch of Porous Titanium Implant
SAN DIEGO, Sept. 5, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Modulus® Cervical, a porous titanium interbody implant for cervical applications. The availability of Modulus Cervical expands the Company's Advanced Materials Science™ (AMS) portfolio to include both Porous PEEK™ and porous titanium offerings for anterior cervical discectomy and fusion (ACDF) techniques, a commonly performed surgery to add...
Aug 28, 2019 08:33 am ET
NuVasive Announces Jerome Bettis, NFL Pro Football Hall of Famer, as Brand Ambassador
SAN DIEGO, Aug. 28, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced Jerome Bettis, NFL Pro Football Hall of Famer and 2006 Super Bowl champion, will serve as a Company brand ambassador. The former Pittsburg Steelers running back will share his personal experience with NuVasive's XLIF® spine surgery to raise awareness about less invasive surgery, which has been linked to better outcomes for patients....
Aug 27, 2019 09:00 am ET
Alphatec Announces Favorable Judgment in NuVasive v. Miles Lawsuit
Alphatec Holdings, Inc. (“ATEC” or “the Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today that the Delaware Chancery Court entered summary judgment in favor of its...
Aug 26, 2019 04:03 pm ET
NuVasive to Participate in Investor Events in September 2019
SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in the following investor events in September: ...
Aug 20, 2019 08:33 am ET
NuVasive Expands its Advanced Materials Science™ Portfolio to Offer Porous Titanium Spine Implants for all TLIF Procedures
SAN DIEGO, Aug. 20, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Modulus® TLIF-A, a porous titanium spine implant engineered for the transforaminal lumbar interbody fusion (TLIF) procedure. This offering completes the Company's Advanced Materials Science™ (AMS) portfolio for all major posterior interbody fusion techniques used in TLIF, the most commonly performed procedure in the spine industry. ...
Aug 14, 2019 08:30 am ET
NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice® System for Limb Lengthening
SAN DIEGO, Aug. 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced a milestone of 10,000 implants of the Precice® system for conditions related to limb lengthening and reconstruction from NuVasive Specialized Orthopedics™. The Precice system is an internal nail that once implanted, utilizes an External Remote Controller (ERC) to non-invasively lengthen the limb. ...
Aug 08, 2019 06:00 am ET
NuVasive Presents Long-Term Strategy and Financial Outlook at 2019 Investor Day
SAN DIEGO, Aug. 8, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today is hosting its 2019 Investor Day in New York City with presentations by Chief Executive Officer J. Christopher Barry and other members of the management team. ...
Jul 30, 2019 04:02 pm ET
NuVasive Announces Second Quarter 2019 Financial Results
SAN DIEGO, July 30, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended June 30, 2019....
Jul 15, 2019 04:05 pm ET
NuVasive Announces Conference Call and Webcast of Second Quarter 2019 Results
SAN DIEGO, July 15, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its second quarter 2019 earnings results on Tuesday, July 30, 2019 after the close of the market....
Jul 15, 2019 08:30 am ET
Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D.
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced it has further strengthened and diversified its Board with the appointments of Peter Farrell,...
Jul 11, 2019 08:30 am ET
NuVasive to Participate as Double Diamond Sponsor at 2019 International Meeting on Advanced Spine Techniques
SAN DIEGO, July 11, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company is continuing its commitment to the Scoliosis Research Society as a Double Diamond sponsor of the 26th International Meeting on Advanced Spine Techniques (IMAST) being held July 17-20, 2019 at the RAI Amsterdam Convention Centre. NuVasive will highlight its leading solutions for adult and pediatric complex spine surgery and comprehensive approach to ...
Jul 10, 2019 08:30 am ET
NuVasive Launches Pulse™-The First Integrated Technology Platform to Enable Better Spine Surgery
SAN DIEGO, July 10, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the launch of the Pulse™ integrated technology platform. Pulse is the first, single platform to include multiple technologies designed to help surgeons adopt more efficient, less disruptive surgical approaches in all spine procedures. Engineered to improve workflow, reduce variability and increase surgical reproducibility, Pulse addresses a broader range of clinica...
May 14, 2019 08:30 am ET
NuVasive To Participate As Global Partner At 12th Annual Society Of Lateral Access Surgery Meeting
SAN DIEGO, May 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company continues its commitment to the Society of Lateral Access Surgery (SOLAS) as a Global Partner, the leading sponsorship level in the partnership program, at the 12th annual SOLAS meeting being held May 16-18, 2019 in Miami, Florida. NuVasive will also participate in exhibit and workshop programs, featuring its comprehensive approach to lateral single-posi...
May 06, 2019 04:05 pm ET
NuVasive To Present At The Bank of America Merrill Lynch Healthcare Conference 2019
SAN DIEGO, May 6, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will present at the Bank of America Merrill Lynch Healthcare Conference 2019 at the Encore Hotel in Las Vegas on Wednesday, May 15, 2019, at 1:40 p.m. PT/4:40 p.m. ET. ...
May 01, 2019 04:02 pm ET
NuVasive Announces First Quarter 2019 Financial Results
SAN DIEGO, May 1, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended March 31, 2019....
Apr 22, 2019 08:30 am ET
Clinical Study Demonstrates NuVasive Cohere® Porous PEEK™ Spinal Interbody Promotes Improved Early Outcomes Over Structural Allograft And Smooth PEEK
SAN DIEGO, April 22, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the study "Early Clinical Outcomes Comparing Porous PEEK, Smooth PEEK, and Structural Allograft Interbody Devices for Anterior Cervical Discectomy and Fusion," published online in the Journal of Spine & Neurosurgery, which concludes that the NuVasive proprietary Cohere® Porous polyetheretherketone (PEEK) implant demonstrates a clear benefit in p...
Apr 15, 2019 04:05 pm ET
NuVasive Announces Conference Call And Webcast Of First Quarter 2019 Results
SAN DIEGO, April 15, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its first quarter 2019 earnings results on Wednesday, May 1, 2019 after the close of the market....
Apr 11, 2019 05:30 am ET
Nuvasive Advances Lateral Single-Position Surgery With Introduction Of X360™ System At AANS 2019
SAN DIEGO, April 11, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will introduce the X360™ system integrated with Pulse™ for lateral single-position surgery at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting being held April 13–17, 2019 in San Diego, California. ...
Apr 05, 2019 08:30 am ET
NuVasive LessRay® Platform Wins Top Honor At 2019 Edison Awards
SAN DIEGO, April 5, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRay® radiation reduction and workflow enhancement platform was voted a gold winner in the advanced surgical instruments category at the 2019 Edison Awards™ held in New York City on April 4. ...
Apr 01, 2019 08:30 am ET
NuVasive Proprietary Porous PEEK™ Technology Used In First XLIF® Spine Surgery Cases
SAN DIEGO, April 1, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the first-case uses of Cohere® XLIF, the first-of-its-kind lateral Porous PEEK™ implant for XLIF® and lateral single-position surgery. The NuVasive Advanced Materials Science™ implant portfolio will remain on the forefront of innovation by incorporating Porous PEEK technology into its implants for lateral single-position surgery and beyond....
Mar 06, 2019 03:05 pm ET
NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At Spine Summit 2019
SAN DIEGO, March 6, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its participation in and sponsorship of Spine Summit 2019 – 35th Annual Meeting of the Section on Disorders of the Spine and Peripheral Nerves, held March 14–17, 2019 at the Fountainebleau Miami Beach. NuVasive will facilitate surgeon education experiences at the summit through participation in a surgery lab featuring the latest advances in lateral single-po...
Mar 06, 2019 07:55 am ET
Research Report Identifies E*TRADE Financial, Kennedy-Wilson, Alteryx, PTC Therapeutics, Ocean Power Technologies, and NuVasive with Renewed Outlook — Fundamental Analysis, Calculating Forward Movemen
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of E*TRADE Financial Corporation (NASDAQ:ETFC), Kennedy-Wilson Holdings...
Mar 05, 2019 03:05 pm ET
NuVasive To Participate In Cowen And Company 39th Annual Health Care Conference
SAN DIEGO, March 5, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will present at the Cowen and Company 39th Annual Health Care Conference at The Boston Marriott Copley Place in Boston on Tuesday, March 12, 2019, at 9:20 a.m. ET / 6:20 a.m. PT. ...
Feb 21, 2019 03:05 pm ET
NuVasive To Present At 8th Annual Leerink Partners Global Healthcare Conference
SAN DIEGO, Feb. 21, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will present at the 8th Annual Leerink Partners Global Healthcare Conference at the Lotte New York Palace Hotel in New York City on Thursday, Feb. 28, 2019 at 9 a.m. ET / 6 a.m. PT.  ...
Feb 20, 2019 03:02 pm ET
NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results
SAN DIEGO, Feb. 20, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter and full year ended Dec. 31, 2018....
Feb 19, 2019 07:30 am ET
NuVasive's Proprietary Magnetic Implant System To Be Used In First-Of-Its-Kind, All-Internal Bone Transport System
SAN DIEGO, Feb. 19, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) – as well as European CE mark approval – for use of its Precice® Bone Transport System, the only all-internal system of its kind on the market indicated for use in segmental bone loss treatment in the tibia and femur resulting from trauma or infection. The Precice Bone Transport System jo...
Feb 13, 2019 07:50 am ET
New Research: Key Drivers of Growth for Plains Group Holdings, Cooper Tire & Rubber, NuVasive, Envestnet, Pacific Ethanol, and Mistras Group — Factors of Influence, Major Initiatives and Sustained Pro
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Plains Group Holdings, L.P. (NYSE:PAGP), Cooper Tire & Rubber Company...
Feb 11, 2019 09:00 am ET
Alphatec Announces Stay of Court Proceedings in NuVasive Patent Lawsuit
Alphatec Holdings, Inc. (“ATEC” or “the Company”) (Nasdaq: ATEC) today announced several favorable developments in its ongoing patent litigation with NuVasive, Inc. (Nasdaq: NUVA). On February 6, 2019, the United States District Court for the...
Jan 29, 2019 03:05 pm ET
NuVasive Announces Conference Call And Webcast Of Fourth Quarter And Full Year 2018 Results
SAN DIEGO, Jan. 29, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its fourth quarter and full year 2018 earnings results on Wednesday, Feb. 20, 2019 after the close of the market....
Jan 07, 2019 07:30 am ET
NuVasive Announces Preliminary Unaudited Fourth Quarter And Full Year 2018 Revenue Results
SAN DIEGO, Jan. 7, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced preliminary unaudited revenue results for the fourth quarter and full year 2018. The Company expects fourth quarter 2018 revenue to be approximately $288 million and full year 2018 revenue to be approximately $1,102 million. ...
Jan 03, 2019 07:30 am ET
NuVasive CEO J. Christopher Barry Announces New Organizational Structure And Leadership Team
SAN DIEGO, Jan. 3, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced a new organizational structure and associated executive team that chief executive officer (CEO) J. Christopher (Chris) Barry has selected to lead the Company's next phase of growth and innovation. Barry joined NuVasive as CEO on November 5, 2018....
Dec 27, 2018 03:05 pm ET
NuVasive To Participate In 37th Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Dec. 27, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will present at the 37th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco on Monday, Jan. 7, 2019, at 3:30 p.m. PT / 6:30 p.m. ET. ...
Dec 11, 2018 07:45 am ET
New Research Coverage Highlights Facebook, Korn/Ferry International, NuVasive, Sonic Automotive, B Communications, and Marin Software — Consolidated Revenues, Company Growth, and Expectations for 2018
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Facebook, Inc. (NASDAQ:FB), Korn/Ferry International (NYSE:KFY),...
Dec 10, 2018 07:30 am ET
NuVasive Grows Cervical Spinal Interbody Portfolio With PEEK Corpectomy Implant
SAN DIEGO, Dec. 10, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded use of its Monolith® Corpectomy System, providing surgeons with a modular PEEK interbody solution for cervical corpectomy procedures. ...
Nov 19, 2018 03:05 pm ET
NuVasive To Participate In The 30th Annual Piper Jaffray Healthcare Conference
SAN DIEGO, Nov. 19, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will be presenting at the Piper Jaffray 30th Annual Healthcare Conference at the Lotte New York Palace in New York City on Thursday, November 29, 2018 at 9:30 a.m. ET / 6:30 a.m. PT....
Nov 15, 2018 07:30 am ET
NuVasive Launches First-Of-Its-Kind Brigade® Lateral Implant And Instrumentation Optimized For Lateral Anterior Lumbar Interbody Fusion Spine Surgery
SAN DIEGO, Nov. 15, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the U.S. commercial launch of Brigade® Lateral, the industry's first interbody implant and instrumentation optimized for lateral anterior lumbar interbody fusion (ALIF) spine surgery. ...
Nov 08, 2018 03:05 pm ET
NuVasive's Proprietary Porous PEEK™ Implant To Be Used In Flagship XLIF® Procedure
SAN DIEGO, Nov. 8, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of its COHERE® Porous PEEK™ implant in eXtreme Lateral Interbody Fusion (XLIF®) surgical spine procedures. ...
Nov 02, 2018 08:55 am ET
New Research: Key Drivers of Growth for Edison International, NuVasive, LogMein, Anika Therapeutics, First Industrial Realty Trust, and ON Semiconductor — Factors of Influence, Major Initiatives and S
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Edison International (NYSE:EIX), NuVasive, Inc. (NASDAQ:NUVA), LogMein,...
Oct 30, 2018 04:02 pm ET
NuVasive Reports Third Quarter 2018 Financial Results
SAN DIEGO, Oct. 30, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced financial results for the quarter ended September 30, 2018.  ...
Oct 19, 2018 08:30 am ET
NuVasive Names J. Christopher Barry To Succeed Gregory T. Lucier As Chief Executive Officer; Lucier To Remain Chairman Of The Board
SAN DIEGO, Oct. 19, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its Board of Directors has named J. Christopher Barry to succeed Gregory T. Lucier as chief executive officer (CEO) effective November 5, 2018. Mr. Barry will join the NuVasive Board of Directors; Mr. Lucier will continue to serve as chairman of the Board. ...
Oct 11, 2018 04:05 pm ET
NuVasive Announces Conference Call And Webcast Of Third Quarter 2018 Results
SAN DIEGO, Oct. 11, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its third quarter 2018 earnings results on Tuesday, October 30, 2018 after the close of the market. ...
Oct 09, 2018 02:30 am ET
NuVasive Announces Strategic Partnership With Biedermann Technologies To Access Intellectual Property And Co-Develop State-of-the-Art Complex Spine Solutions
SAN DIEGO and DONAUESCHINGEN, GERMANY, Oct. 9, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it has entered into a strategic partnership with Biedermann Technologies GmbH & Co. KG, a company that holds a broad and extensive patent and technology portfolio in the fields of spinal and extremity surgery, based in Donaueschingen, Germany. ...
Oct 08, 2018 08:30 am ET
NuVasive Clinical Services Awarded Sole Source Intraoperative Neuromonitoring Services Contract With Premier
SAN DIEGO, Oct. 8, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive Clinical Services has been awarded a three-year, sole source supplier contract for Intraoperative Neuromonitoring (IONM) Services with Premier. Effective November 1, 2018, the new contract allows Premier members the option to take advantage of special pricing and terms pre-negotiated by Premier for IONM services provided by NuVasive Clinical Services (...
Oct 04, 2018 04:05 pm ET
NuVasive To Showcase Comprehensive Solutions For Complex Spinal Deformities At Scoliosis Research Society Annual Meeting
SAN DIEGO, Oct. 4, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will highlight several of its latest spinal innovations to treat complex spinal deformities at the Scoliosis Research Society (SRS) Annual Meeting held October 10-13, 2018 in Bologna, Italy. As a Double Diamond Sponsor of SRS, NuVasive continues to demonstrate a strong leadership position in offering transformative solutions within the complex adult and pediatric...
Oct 01, 2018 07:35 am ET
New Research Coverage Highlights Dillard's, AMC Entertainment, Patterson Companies, NuVasive, Life Storage, and Ambac Financial Group — Consolidated Revenues, Company Growth, and Expectations for 2018
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Dillard's, Inc. (NYSE:DDS), AMC Entertainment Holdings, Inc....
Sep 26, 2018 08:30 am ET
NuVasive Enrolls First Patients In Long-Term, Controlled Study Evaluating Advanced Implants' Effects On Fusion And Clinical Outcomes In XLIF® Procedures
SAN DIEGO, Sept. 26, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it enrolled its first patients in a prospective, multicenter study evaluating advanced spinal implants used in XLIF® procedures and their effect on long-term patient outcomes....
Sep 25, 2018 08:30 am ET
NuVasive To Demonstrate Pulse™ Surgical Automation Platform At NASS 2018 Annual Meeting
SAN DIEGO, Sept. 25, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that live demonstrations of the Pulse™ surgical automation platform with integration of the Siemens Healthineers' Cios Spin* cutting-edge mobile 3D-imaging will be held throughout the North American Spine Society (NASS) 2018 Annual Meeting, September 26-29, 2018....
Sep 24, 2018 08:30 am ET
NuVasive Expands Biologics Portfolio To Meet Clinical And Economic Needs
SAN DIEGO, Sept. 24, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the U.S. commercial launch of three new biologics offerings to include traditional bone allograft, amniotic membrane DS and additional form factors to the current PropelTM DBM product line. This portfolio expansion demonstrates the Company's strategic efforts to deliver the most differentiated biologics portfolio in the spine industry....
Sep 21, 2018 08:30 am ET
Scott Huennekens To Join NuVasive Board Of Directors
SAN DIEGO, Sept. 21, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Scott Huennekens to the Company's Board of Directors, effective October 1, 2018. ...
Sep 20, 2018 08:30 am ET
NuVasive To Showcase Spine Precision Surgery Leading To Smarter, More Predictable Clinical Outcomes At NASS 2018
SAN DIEGO, Sept. 20, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will highlight the Company's latest disruptive spine technology at the North American Spine Society (NASS) Annual Meeting held September 26-29, 2018 in Los Angeles, California, at the Los Angeles Convention Center. ...
Sep 11, 2018 08:30 am ET
NuVasive Clinical Services™ Leader Richard Vogel Co-Chairs And Lectures At American Society Of Neurophysiological Monitoring 2018 Fall Symposium
SAN DIEGO, Sept. 11, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced Richard Vogel, Ph.D., DABNM, FASNM, director of Strategic Initiatives at NuVasive Clinical ServicesTM (NCS), will co-chair, moderate and lecture at the American Society of Neurophysiological Monitoring (ASNM) 2018 Fall Symposium held September 15-16, 2018, in Nashville, Tennessee. ASNM is the largest professional society in the world dedicated to the advancement o...
Sep 06, 2018 04:05 pm ET
NuVasive To Present At The Morgan Stanley 16th Annual Global Healthcare Conference
SAN DIEGO, Sept. 6, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will present at the Morgan Stanley 16th Annual Global Healthcare Conference at the Grand Hyatt New York in New York City on Wednesday, September 12, 2018, at 2:15 p.m. ET/11:15 a.m. PT....
Sep 05, 2018 08:30 am ET
NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX® 20 Degree Implant
SAN DIEGO, Sept. 5, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the launch of its TLX® 20 degree expandable spinal interbody implant with a first-of-its-kind oblique profile designed for transforaminal lumbar interbody fusion (TLIF) procedures. This product launch is another step forward in the Company's strategy to build a comprehensive expandable portfolio to best support optimal clinical outcomes....
Sep 04, 2018 04:02 pm ET
NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum
SAN DIEGO, Sept. 4, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will showcase industry-leading solutions for creating better clinical outcomes for spine procedures at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum being held September 6-8, 2018, in Las Vegas at Caesars Palace.  ...
Aug 16, 2018 08:40 am ET
NuVasive Appoints Dale Wolf To Lead Ohio Manufacturing Facility
SAN DIEGO, Aug. 16, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Dale Wolf as vice president, Manufacturing, who will oversee the Company's West Carrollton, Ohio manufacturing facility. ...
Aug 09, 2018 08:30 am ET
NuVasive and Siemens Healthineers partner to transform spine surgery
SAN DIEGO and ERLANGEN, Germany, Aug. 9, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) and Siemens Healthineers today announced a strategic partnership focused on technology development, marketing and commercial activities to advance clinical outcomes in minimally invasive spine surgery. NuVasive is an innovation leader in spine health technology, focused on transforming spine surgery with minimally disruptive, predictable and clinically reproducible procedurally-integrated solutions, while Siemens Healthineers offers surgeons a broad portfolio of imaging systems including 3D imaging fo...
Jul 31, 2018 04:05 pm ET
NuVasive Announces Second Quarter 2018 Financial Results
SAN DIEGO, July 31, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced financial results for the quarter ended June 30, 2018.  ...
Jul 27, 2018 08:30 am ET
NuVasive Unveils Spine's First Integrated Surgical Automation Platform
SAN DIEGO, July 27, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Pulse™ surgical automation platform has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Pulse is the foundation for Surgical Intelligence™, the Company's ecosystem enabling better surgery. Pulse introduces 2D- and 3D-navigation and smart imaging capabilities while integrating the Company's leading neuromonitoring, surgical planning, ...
Jul 19, 2018 05:30 am ET
Nuvasive Launches MAGEC X For Early Onset Scoliosis Treatment
SAN DIEGO, July 19, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the U.S. launch of MAGEC X, a new procedural solution within the MAGEC product family that addresses Early Onset Scoliosis (EOS)....
Jul 16, 2018 05:30 am ET
NuVasive Portfolio Introduces Low-Profile Modular Implants For Posterior Fixation
SAN DIEGO, July 16, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the launch of Reline MAS Midline (RMM), the next evolution of the Reline system that provides procedural versatility in a compact midline construct.  ...
Jul 11, 2018 04:10 pm ET
NuVasive Announces Conference Call And Webcast Of Second Quarter 2018 Results
SAN DIEGO, July 11, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will release its second quarter 2018 earnings results on Tuesday, July 31, 2018 after the close of the market. ...
Jul 10, 2018 05:30 am ET
NuVasive Unveils Newest Addition To Lateral Procedural Solutions At IMAST 2018
SAN DIEGO, July 10, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will officially unveil its XLIF® Lordotic Expandable (XLX) Interbody System, which just received 510(k) clearance from the U.S. Food and Drug Administration (FDA), at the 25th International Meeting on Advanced Spine Techniques (IMAST) in Los Angeles, July 11-14, 2018. NuVasive is a Double Diamond Sponsor of the conference, reflecting its continued suppo...
Jul 09, 2018 05:30 am ET
Research Highlights The Importance Of Spinal Alignment In All, Not Just Deformity, Lumbar Fusions
SAN DIEGO, July 9, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that the first peer-reviewed publication from the NuVasive-sponsored multicenter Integrated Global Alignment (iGA®) study is now available in the journal Spine. This initial study evaluated the preoperative prevalence and incidence of postoperative spinopelvic malalignment in patients who underwent one- or two-level lumbar fusions for degenerative (non-deformity) in...
Jul 02, 2018 08:00 am ET
Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of NuVasive, Inc. -- NUVA
Pomerantz LLP announces that the United States District Court Southern District of California has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of NuVasive, Inc....
Jun 20, 2018 08:30 am ET
First Porous PEEK Spinal Implant Clinical Study Validates NuVasive Advanced Materials Science Technology In Treating Degenerative Cervical Disc Disease
SAN DIEGO, June 20, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the results of the study "Early Outcomes of Anterior Cervical Discectomy and Fusion Using Porous PEEK™ Interbody Fusion Device," published online in the Journal of Spine & Neurosurgery, which concludes that NuVasive patented porous polyetheretherketone (PEEK) technology is a clinically viable alternative for improving osseointegration and fusion rates of interb...
Jun 15, 2018 08:30 am ET
Recent Analysis Shows NuVasive, Ecolab, Roku, Northern Trust, Sea Limited, and Twenty-First Century Fox Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NuVasive, Inc. (NASDAQ:NUVA), Ecolab Inc. (NYSE:ECL), Roku, Inc....
Jun 12, 2018 08:30 am ET
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
SAN DIEGO, June 12, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the U.S. launch of AttraX® Scaffold, an absorbent ceramic-collagen bone graft with an optimized surface that has been validated in preclinical testing to drive increased bone formation and faster fusion than traditional ceramic bone grafts.1 ...
Jun 11, 2018 08:30 am ET
NuVasive Announces Key Finance Appointments
SAN DIEGO, June 11, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointments of Lisa Pecora as vice president, Global Commercial Finance and Tristan Ribar as vice president, Corporate Finance and Treasury. In addition, Marc Rosenbaum is promoted to corporate controller....
Jun 05, 2018 04:02 pm ET
NuVasive To Present At The Goldman Sachs Annual Global Healthcare Conference
SAN DIEGO, June 5, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will present at the Goldman Sachs 39th Annual Global Healthcare Conference at the Terranea resort in Rancho Palos Verdes, Calif., Tuesday, June 12, 2018, at 11:20 a.m. PT/2:20 p.m. ET....
May 31, 2018 11:30 am ET
Kuros Biosciences to Propose Appointment of New Board Members at AGM
Kuros Biosciences (SIX:KURN) will propose the appointment of CEO Joost de Bruijn, as well as three new independent non-executive directors at its 2018 Annual General Meeting (AGM) on 14 June.  Shareholder approval will be sought for the...
May 29, 2018 08:42 am ET
Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne
Arcturus Therapeutics Ltd. (NASDAQ:ARCT) (“Arcturus” or the “Company), a leading RNA medicines company, today announced that, as part of a settlement agreement, it has appointed four new independent directors, Dr. Peter Farrell, Mr. Andrew Sassine,...
May 23, 2018 08:30 am ET
Nuvasive SpineTRACK Registry Reaches Significant Enrollment Milestone Of 10,000 Patients
SAN DIEGO, May 23, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that the Company's SpineTRACK Registry has reached a significant enrollment milestone of 10,000 patients from more than 50 surgeons in the United States since its inception in 2011. This milestone illustrates not only the continued utility of SpineTRACK to surgeon partners, but also confirms the NuVasive commitment to research, data collection and quality of care ov...
May 22, 2018 08:30 am ET
NuVasive PRECICE STRYDE™ System Used In First Patient For Stature Lengthening By International Limb Lengthening Expert
SAN DIEGO, May 22, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the new PRECICE STRYDE™ system from NuVasive Specialized Orthopedics™ (NSO) was used in the first set of patients by internationally recognized limb lengthening and reconstruction expert Dr. Dror Paley. Built on five years of clinical experience, PRECICE STRYDE is a market-leading internal system available for stature lengthening and limb reconstruction....
May 16, 2018 04:02 pm ET
NuVasive Sponsors SOLAS 2018, Hosts Workshop On Latest Lateral Innovations
SAN DIEGO, May 16, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that the Company is a sponsor of the Society of Lateral Access Surgery (SOLAS) and its annual meeting being held May 17-19, 2018, in San Diego. NuVasive was recently recognized by SOLAS for its longstanding commitment and the first-ever Global Partner in its new partnership program this year. ...
May 09, 2018 04:02 pm ET
NuVasive To Present At The Bank of America Merrill Lynch 2018 Healthcare Conference
SAN DIEGO, May 9, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will present at the Bank of America Merrill Lynch 2018 Healthcare Conference at the Encore Hotel in Las Vegas on Tuesday, May 15, 2018, at 8:40 a.m. PT/11:40 a.m. ET....
May 08, 2018 04:02 pm ET
NuVasive Unveils Newest Additions To Early Onset Scoliosis Portfolio At POSNA Annual Meeting
SAN DIEGO, May 8, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will officially unveil MAGEC X, the newest offering in its Early Onset Scoliosis (EOS) procedural solutions portfolio at the POSNA Annual Meeting in Austin, Texas. NuVasive is a Double Diamond Sponsor of the conference, reflecting its continued support of advancing pediatric care....
May 01, 2018 04:02 pm ET
NuVasive Announces First Quarter 2018 Financial Results
SAN DIEGO, May 1, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced financial results for the quarter ended March 31, 2018.  ...
Apr 24, 2018 04:02 pm ET
NuVasive Sponsors AANS 2018, Hosts Workshops And Presentations On Latest Innovations
SAN DIEGO, April 24, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company is a sponsor of the American Association of Neurological Surgeons (AANS) Annual Scientific meeting being held April 28-May 2, 2018, in New Orleans, at the Earnest N. Morial Convention Center. NuVasive will host a hands-on workshop featuring the latest advances in Lateral Single-Position surgery, technology to reduce OR radiation and developments in 3D-...
Apr 19, 2018 07:30 am ET
New Research: Key Drivers of Growth for NuVasive, Apptio, Apollo Investment, Uranium Energy, AECOM, and US Foods Holding — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, April 19, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NuVasive, Inc. (NASDAQ:NUVA), Apptio Inc. (NASDAQ:APTI),...
Apr 10, 2018 04:02 pm ET
NuVasive Announces Conference Call And Webcast Of First Quarter 2018 Results
SAN DIEGO, April 10, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that its first quarter 2018 earnings announcement will take place on Tuesday, May 1, 2018, after the close of the market....
Apr 05, 2018 04:02 pm ET
NuVasive Sponsors ISASS 2018, Hosts Workshops And Presentations
SAN DIEGO, April 5, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company is a sponsor of the International Society for the Advancement of Spine Surgery, 18th Annual Conference (ISASS) being held April 11-13, 2018, in Toronto, at the Metro Toronto Convention Centre. NuVasive will host a hands-on workshop featuring the latest advances in Lateral Single-Position solutions, as well as a number of podium presentations at ISASS 20...
Apr 02, 2018 04:02 pm ET
NuVasive Portfolio Now Includes ALIF Retractor Platform For Lateral And Supine Approaches
SAN DIEGO, April 2, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the launch of ALIF (Anterior Lumbar Interbody Fusion) Access, the Company's first-ever MAS® (Maximum Access Surgery) ALIF retractor platform for both lateral and supine spine surgery approaches. ...
Mar 29, 2018 04:02 pm ET
Research Shows NuVasive Porous PEEK Structure Maintains High Porosity After Impaction
SAN DIEGO, March 29, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the results of the study "Impaction durability of Porous PEEK™ and titanium-coated PEEK interbody fusion devices," published online in The Spine Journal, which concluded advantages of the NuVasive Porous PEEK material over titanium-coated PEEK devices1. ...
Mar 05, 2018 03:02 pm ET
NuVasive to Participate in Investor Events in March 2018
SAN DIEGO, March 5, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will participate in the following investor events in March 2018:...
Feb 26, 2018 03:02 pm ET
NuVasive Reports Fourth Quarter and Full Year 2017 Financial Results
SAN DIEGO, Feb. 26, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today financial results for the quarter and full year ended Dec. 31, 2017. ...
Feb 26, 2018 12:15 pm ET
NuVasive, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 26, 2018 / NuVasive, Inc. (NASDAQ: NUVA) will be discussing their earnings results in their Q4 Earnings Call to be held on February 26, 2018 at 4:30 PM Eastern Time.
Feb 20, 2018 03:05 pm ET
NuVasive SpineTRACK Registry Named Qualified Clinical Data Registry By Centers Of Medicare And Medicaid Services
SAN DIEGO, Feb. 20, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that the Company's SpineTRACK Registry has received the designation of Qualified Clinical Data Registry (QCDR) by the Centers of Medicare and Medicaid Services (CMS) for the 2018 Merit-based Incentive Payment System (MIPS) reporting year. As a result, SpineTRACK participants can now use the platform to earn Medicare payment incentives. ...
Feb 09, 2018 07:35 am ET
Research Report Identifies Ichor, TASER International, Premier, NuVasive, Verastem, and BLACKLINE INC with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, Feb. 09, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ichor Holdings, Ltd. (NASDAQ:ICHR), TASER International,...
Feb 08, 2018 03:05 pm ET
John DeFord To Join NuVasive Board Of Directors
SAN DIEGO, Feb. 8, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced the appointment of John A. DeFord, Ph.D. to the Company's Board of Directors, effective upon the filing of the Company's Form 10-K with the Securities and Exchange Commission. ...
Jan 08, 2018 07:30 am ET
NuVasive Announces Preliminary Unaudited Full Year 2017 Revenue Results And Preliminary 2018 Outlook
SAN DIEGO, Jan. 8, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced preliminary unaudited revenue results for the fourth quarter and full year 2017.  The Company expects fourth quarter 2017 revenue to be approximately $272 million and full year 2017 revenue to be approximately $1,030 million and in line with the guidance provided on Oct 24, 2017. ...
Jan 04, 2018 07:30 am ET
NuVasive Extends First-Of-Its-Kind Porous PEEK Interbody To TLIF And PLIF Procedures
SAN DIEGO, Jan. 4, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today the launch of the Company's COALESCETM Thoracolumbar Interbody Fusion Device as well as FDA 510(k) clearance for expanded indications of its COHERE® Cervical Interbody Fusion Device. The launch and updated claims follow the NuVasive September 2017 acquisition of Vertera Spine, developers of highly innovative interbody implants for spinal fusion using patented porous...
Jan 03, 2018 03:02 pm ET
NuVasive To Present At The 36th Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 3, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will present at the 36th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco on Monday, Jan. 8, 2018, at 1:30 p.m. PT / 4:30 p.m. ET....
Dec 21, 2017 07:30 am ET
NuVasive Comments On Expected Impact Of U.S. Tax Reform
SAN DIEGO, Dec. 21, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today the potential implications to its business based on the recent passage by the U.S. Congress and soon-to-occur signing by President Trump of the tax bill, An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018, resulting in the reduction of the U.S. corporate tax rate from 35 percent to approx...
Dec 14, 2017 03:02 pm ET
NuVasive Appoints Experienced Spine Executive Michael Piccirillo To Lead New Global Surgeon Education Platform
SAN DIEGO, Dec. 14, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today the expansion of its renowned surgeon education program into a Clinical Professional Development (CPD) global platform for surgeons that integrates surgical training with professional development. This new initiative will be led by Michael Piccirillo, a recognized expert in designing and executing spine educational curriculums and surgeon communities in more than 8...
Dec 12, 2017 03:02 pm ET
NuVasive To Acquire SafePassage
SAN DIEGO, Dec. 12, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, and SafePassage™, a privately-held provider of intraoperative neurophysiological monitoring (IONM) services, announced today that they have entered into a definitive agreement under which NuVasive will acquire SafePassage. Terms of the deal were not disclosed. ...
Nov 20, 2017 07:55 am ET
Research Report Identifies Hill-Rom, TASER International, Synchronoss Technologies, NuVasive, Verastem, and Roku with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, Nov. 20, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Hill-Rom Holdings Inc (NYSE:HRC), TASER International,...
Nov 16, 2017 08:30 am ET
NuVasive To Participate In The 29th Annual Piper Jaffray Healthcare Conference
SAN DIEGO, Nov. 16, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that NuVasive management will be presenting at the Piper Jaffray 29th Annual Healthcare Conference at the Lotte New York Palace in New York City on Wednesday, November 29 at 8:30 a.m. ET / 5:30 a.m. PT....
Oct 31, 2017 03:33 pm ET
Glancy Prongay & Murray LLP Commences Investigation on Behalf of NuVasive, Inc. Investors (NUVA)
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of NuVasive, Inc. (“NuVasive” or the “Company”) (NASDAQ:
Oct 25, 2017 09:30 am ET
NuVasive Unveils Latest Innovation At NASS 2017
SAN DIEGO, Oct. 25, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will highlight the Company's latest disruptive spine technology innovation at the North American Spine Society (NASS) Annual Meeting held October 25-28, 2017 in Orlando, Fla. At the event, NuVasive will also celebrate 15 years of leading lateral spine surgery with the Company's flagship XLIF procedure, highlighting its commitment to lead, expand and advance spin...
Oct 24, 2017 05:04 pm ET
NuVasive Announces $100 Million Share Repurchase Program
SAN DIEGO, Oct. 24, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that its Board of Directors approved a share repurchase program authorizing the purchase of up to $100 million of the Company's common stock over a three-year period commencing October 25, 2017....
Oct 24, 2017 05:02 pm ET
NuVasive Reports Third Quarter 2017 Financial Results
SAN DIEGO, Oct. 24, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today financial results for the quarter ended September 30, 2017.  ...
Oct 23, 2017 09:30 am ET
NuVasive Extends Its Leadership As Lateral Spine Technology Innovator With New Lateral Single-Position Surgery Procedure
SAN DIEGO, Oct. 23, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced new lateral solutions that enable surgeons to perform lateral single-position surgery and expand the Company's comprehensive lateral portfolio....
Oct 18, 2017 05:05 pm ET
NuVasive Launches New 3D-Printed Porous Titanium Implant In Expanding Advanced Materials Science Portfolio
SAN DIEGO, Oct. 18, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the launch of Modulus® XLIF® titanium implants. The new 3D-printed, fully porous device provides a differentiated offering for the Company's flagship XLIF procedure, highlighting a continued commitment to innovation in developing first-of-its-kind technology to support its leading lateral spine procedure. ...
Oct 16, 2017 09:30 am ET
NuVasive Receives Expanded FDA 510(k) Clearance For TLX Interbody System Used In TLIF Procedures
SAN DIEGO, Oct. 16, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced an expanded U.S. Food and Drug Administration (FDA) 510(k) clearance of the Company's TLX interbody system, used in the leading spinal fusion surgery. New clearance introduces an expandable 20 degree cage and broader indications for use, including use with allogeneic bone graft and use in additional levels of the spine....
Oct 12, 2017 09:30 am ET
NuVasive Receives Expanded FDA 510(k) Clearance For Innovative Magnetic Limb Lengthening Technology
SAN DIEGO, Oct. 12, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that it has received expanded 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Company's PRECICE® system from NuVasive Specialized Orthopedics™ (NSO) with expanded indications that now include open and closed fracture fixation, pseudoarthrosis, malunions, nonunions, and bone transport....
Oct 10, 2017 05:36 pm ET
Nuvasive Files Lawsuit Against Patrick S. Miles To Protect Corporate Assets And Stakeholders' Interests
SAN DIEGO, Oct. 10, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that it has filed a lawsuit in the Delaware Chancery Court against Patrick S. Miles, former vice chairman of the Company and a member of NuVasive's Board of Directors. The lawsuit asserts that before abruptly resigning from the Company to join Alphatec Holdings, Inc. (NASDAQ: ATEC), Mr. Miles engaged in a scheme for over a year to divert corporate opportunities and then anno...
Oct 05, 2017 05:05 pm ET
Nuvasive Announces Conference Call And Webcast Of Third Quarter 2017 Results
SAN DIEGO, Oct. 5, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will release its third quarter 2017 earnings results on Tuesday, October 24, 2017 after the close of the market....
Oct 04, 2017 05:05 pm ET
NuVasive Hosts 2nd Annual Spine Summit Event Focused On The Future Of Spine Care
SAN DIEGO, Oct. 4, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, is hosting the 2nd Annual Spine Summit in San Diego on October 4 – 6, 2017. This unique educational event brings together hospital executives, healthcare leaders, industry visionaries and surgeons to discuss the future of spine care and build out solutions to deliver high-quality care for patients. The opening keynote address features newly named NuVasive spokesman Archie Manning. ...
Sep 13, 2017 08:30 am ET
NuVasive Announces Commercial Launch Of LessRay System Designed To Significantly Reduce Radiation Exposure For Surgeons, Operating Room Staff And Patients
SAN DIEGO, Sept. 13, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the commercial launch of its LessRay® software technology system. The LessRay system, comprised of a propriety software algorithm and hardware components, is designed to help address over exposure to radiation in hospital operating rooms (O.R.), particularly in the case of minimally invasive spine surgery (MIS)....
Sep 07, 2017 11:43 am ET
NuVasive Announces Acquisition Of Vertera Spine
SAN DIEGO, Sept. 7, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the acquisition of Vertera Spine, a privately-held medical device company developing and commercializing highly innovative interbody implants for spinal fusion using patented porous polyetheretherketone (PEEK) technology. Terms of the acquisition were not disclosed. ...
Sep 06, 2017 09:00 am ET
NuVasive Receives FDA 510(k) Clearance For Leading EOS Innovation
SAN DIEGO, Sept. 6 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of the Company's redesigned MAGEC® system with its RELINE® Small Stature system. NuVasive will feature these new product offerings at the Scoliosis Research Society (SRS) 52nd Annual Meeting & Course to be held September 6-9, 2017 in Philadelphia....
Aug 30, 2017 05:05 pm ET
NuVasive To Participate In Investor Events In September 2017
SAN DIEGO, Aug. 30, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that management will participate in the following investor events in September 2017: ...
Aug 29, 2017 09:00 am ET
NuVasive Announces World-Class Innovation Center At San Diego Headquarters
SAN DIEGO, Aug. 29, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the expansion of its San Diego global headquarters, including the creation of an innovation center of excellence where surgeons from around the world will be educated and trained on the latest NuVasive spine technology and procedures designed to drive clinical predictability and improve patients' lives....
Aug 22, 2017 09:00 am ET
InfoBionic Appoints Gene Cattarina to Board of Directors
BOSTON, Aug. 22, 2017 /PRNewswire/ -- InfoBionic, a digital health company focused on creating superior solutions for outpatient cardiac arrhythmia monitoring, has announced the appointment of Gene Cattarina to its Board of Directors. Mr. Cattarina brings over 40 years of experience in numerous senior executive positions at companies in healthcare information systems, products, medical devices, and professional services, and will apply his veteran insights to help InfoBionic continue to scale up commercialization of its market-shifting MoMe® Kardia Software as a Service (SaaS) remote cardiac...
Aug 15, 2017 08:30 am ET
NuVasive Appoints Rajesh J. Asarpota As Chief Financial Officer
SAN DIEGO, Aug. 15, 2017 /PRNewswire/ -- NuVasive, Inc. (Nasdaq: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today the appointment of Rajesh (Raj) J. Asarpota as the Company's new executive vice president and chief financial officer (CFO), effective September 1, 2017....
Aug 02, 2017 02:10 pm ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of NuVasive Inc. (NUVA)
NEW YORK, Aug. 2, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NuVasive Inc. ("NuVasive" or the "Company") (NASDAQ: NUVA). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/nuva....
Jul 28, 2017 10:31 am ET
Options trade ideas released for American Airlines, First Solar, Macy's Incorporated, NuVasive, Inc. and Spirit Airlines
CHICAGO, July 28, 2017 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAL, FSLR, M, NUVA, and SAVE....
Jul 27, 2017 05:05 pm ET
NuVasive Announces New Organizational Structure To Drive Growth And Profitability Goals
SAN DIEGO, July 27, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced a new organizational structure to drive the Company's growth and profitability goals, supporting its strategy to help deliver safer, more predictable spine surgery. ...
Jul 27, 2017 05:02 pm ET
NuVasive Reports Second Quarter 2017 Financial Results
SAN DIEGO, July 27, 2017 /PRNewswire/ -- NuVasive, Inc. (Nasdaq: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today financial results for the quarter ended June 30, 2017.  ...
Jul 10, 2017 05:05 pm ET
NuVasive Leading Sponsor Of IMAST 2017 And Hosting Workshops Featuring Advanced Technologies
SAN DIEGO, July 10, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company is a leading sponsor of the Scoliosis Research Society's (SRS) International Meeting On Advanced Spine Techniques (IMAST) being held July 12-15, 2017 in Cape Town, South Africa. NuVasive will host hands-on workshops featuring the latest advanced technologies in treating scoliosis....
Jul 05, 2017 05:05 pm ET
NuVasive Announces Conference Call And Webcast Of Second Quarter 2017 Results
SAN DIEGO, July 5, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will release its second quarter 2017 earnings results on Thursday, July 27, 2017 after the close of the market....
Jun 05, 2017 08:05 am ET
NuVasive Magnetic, Non-Invasive Platforms Featured In The Journal Of Orthopaedic Trauma Supplement
SAN DIEGO, June 5, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the PRECICE® system and PRECICE UNYTE™ platform from NuVasive Specialized Orthopedics (NSO) are featured in the June 2017 supplement of the Journal of Orthopaedic Trauma (JOT), which demonstrates a lower complication rate, greater patient comfort and faster healing in comparison to traditional treatments1. ...
Jun 01, 2017 08:05 am ET
NuVasive Appoints Skip Kiil As Executive Vice President, International
SAN DIEGO, June 1, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced Skip Kiil is joining the Company as executive vice president, International. In this role, Mr. Kiil will oversee the Company's international operations, reporting to NuVasive's chairman and chief executive officer, Gregory T. Lucier, and serving on the Company's executive leadership team....
May 22, 2017 08:00 am ET
NuVasive Announces Educational Initiatives In Support Of Spine's Fastest Growing Spinal Deformity Portfolio
SAN DIEGO, May 22, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company's increased investment and support of adult and pediatric deformity research, education, and awareness initiatives throughout 2017. ...
May 09, 2017 05:05 pm ET
NuVasive To Present At Bank of America Merrill Lynch 2017 Global Healthcare Conference
SAN DIEGO, May 9, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that management will present at the Bank of America Merrill Lynch 2017 Global Healthcare Conference at the Encore at Wynn Las Vegas on Tuesday, May 16, 2017 at 11:40 a.m. ET / 8:40 a.m. PT. ...
May 02, 2017 05:05 pm ET
NuVasive Announces Sponsorship Of EPOSNA 2017 And Launches New Monthly Pediatric Spinal Deformity Podcast
SAN DIEGO, May 2, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company is a leading sponsor of EPOSNA 2017, the combined meeting of the EPOS (European Paediatric Orthopaedic Society) and POSNA (Pediatric Orthopaedic Society of North America) annual meetings, held this week in Barcelona, Spain. NuVasive also announced the launch of a monthly podcast, MAGEC Matters, featuring interviews with the leading surgeons in pediatric deformity a...
Apr 25, 2017 05:05 pm ET
NuVasive Announces First Quarter 2017 Financial Results
SAN DIEGO, April 25, 2017 /PRNewswire/ -- NuVasive, Inc. (Nasdaq: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today financial results for the quarter ended March 31, 2017.  ...
Apr 20, 2017 05:05 pm ET
NuVasive Unveils New Trauma Portfolio And Virtual Reality Simulation At AANS 2017
SAN DIEGO, April 20, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will showcase the Company's new RELINE® Trauma portfolio and O.R. virtual reality (VR) simulation at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting held April 22-26, 2017 in Los Angeles. ...
Apr 19, 2017 05:05 pm ET
NuVasive Launches New Spinal Trauma Portfolio
SAN DIEGO, April 19, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the launch the new RELINE® Trauma portfolio, which will serve as the Company's foundation to address the estimated $100 million U.S. spine trauma fixation market, currently growing 5.6 percent annually. ...
Apr 12, 2017 09:00 am ET
NuVasive To Feature Proprietary Radiation Reduction Platform At ISASS 2017
SAN DIEGO, April 12, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will showcase the Company's LessRay® software technology at the International Society for Advancement of Spine Surgery's (ISASS) 17th annual conference held April 12-14, 2017 in Boca Raton, Florida. ...
Apr 10, 2017 05:05 pm ET
NuVasive Announces Conference Call And Webcast Of First Quarter 2017 Results
SAN DIEGO, April 10, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will release its first quarter 2017 earnings results on Tuesday, April 25, 2017 after the close of the market....
Mar 29, 2017 10:00 am ET
NuVasive Receives First-Ever FDA Clearance For Cervical Interbody Implant System Used In More Than Two Levels
SAN DIEGO, March 29, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the CoRoent® Small Interbody™ System indicated for intervertebral body fusion at multiple contiguous levels in the cervical spine. This marks the first U.S. clearance for a cervical cage to be used at up to four contiguous levels....
Mar 20, 2017 10:00 am ET
New Evidence-Based Recommendation Released From NICE (U.K.) For Lateral Interbody Fusion
SAN DIEGO, March 20, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced updated guidance from the National Industry for Clinical Excellence (NICE) in the U.K. for lateral interbody fusion in the lumbar spine. NICE stated the evidence on efficacy for lateral interbody fusion is adequate in quality and quantity and the procedure may be used provided that standard arrangements are in place for clinical governance, consent and audit. The majority o...
Mar 02, 2017 05:34 pm ET
NuVasive to Participate in Investor Events in March 2017
SAN DIEGO, March 2, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will participate in the following investor events in March 2017:...
Feb 09, 2017 04:05 pm ET
NuVasive Reports Fourth Quarter And Full Year 2016 Financial Results
SAN DIEGO, Feb. 9, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today financial results for the quarter and full year ended December 31, 2016. Key performance highlights included:...
Feb 06, 2017 08:30 am ET
NuVasive To Present At Leerink Partners 6th Annual Global Healthcare Conference 2017
SAN DIEGO, Feb. 6, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that management will present at the Leerink Partners 6th Annual Healthcare Conference at the Lotte New York Palace Hotel in New York, New York on Wednesday, February 15, 2017 at 11:00 a.m. ET / 8:00 a.m. PT. ...
Jan 13, 2017 11:41 am ET
NuVasive Announces Conference Call and Webcast of Fourth Quarter 2016 Results
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that its fourth quarter and full year 2016 earnings announcement will...
Jan 09, 2017 08:00 am ET
NuVasive Announces Select Preliminary Unaudited Full Year 2016 Financial Results and 2017 Outlook
NuVasive, Inc. (NASDAQ: NUVA)Preliminary full year 2016 revenue of approximately $956 million; reflects 17.9% growth versus prior year, or 17.6% on a constant currency basis Preliminary full year 2016 non-GAAP operating profit margin expected to be...
Jan 04, 2017 04:05 pm ET
NuVasive to Present at the 35th Annual J.P. Morgan Healthcare Conference
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that management will present at the 35th Annual J.P. Morgan...
Dec 29, 2016 07:05 am ET
NuVasive to Resume XLIF Procedures in Japan in First Quarter 2017
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it received approval for instruments used in the eXtreme Lateral...
Dec 01, 2016 07:00 am ET
NuVasive to Showcase Integrated Global Alignment for the Cervical Spine at CSRS 2016
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the exhibiting of the Company's recently launched Integrated Global...
Nov 17, 2016 08:36 pm ET
NuVasive to Participate in the Piper Jaffray 28th Annual Healthcare Conference
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will be presenting at the Piper Jaffray 28th Annual...
Oct 27, 2016 07:05 am ET
NuVasive Secures Magnetic Resonance (MR) FDA Conditional Clearance for MAGEC System
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced FDA clearance for magnetic resonance imaging (MRI) under certain...
Oct 25, 2016 05:10 pm ET
NuVasive First-to-Market With New Spine Innovations Featured at NASS 2016
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the introduction of new spine innovations at the North American Spine...
Oct 25, 2016 05:00 pm ET
NuVasive Reports Third Quarter 2016 Financial Results
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today financial results for the quarter ended September 30, 2016. Third...
Oct 18, 2016 04:05 pm ET
NuVasive Announces Date Change for Conference Call and Webcast of Third Quarter 2016 Results
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that the Company has changed the date of its third quarter 2016...
Oct 03, 2016 07:05 am ET
NuVasive Appoints Joan Stafslien as Executive Vice President, General Counsel
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced Joan Stafslien is joining the Company as executive vice president,...
Sep 26, 2016 04:10 pm ET
NuVasive Announces Conference Call and Webcast of Third Quarter 2016 Results
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery, today announced that the Company will release its third quarter 2016 earnings results before the markets open on Wednesday, October 26,...
Sep 20, 2016 07:14 pm ET
The Cooper Companies Set to Join the S&P 500; Northwestern and NuVasive to Join S&P MidCap 400; SPS Commerce and Fox Factory to Join S&P SmallCap 600
NEW YORK, Sept. 20, 2016 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices effective after the close of trading on Thursday, September 22:...
Sep 19, 2016 07:05 am ET
NuVasive Receives FDA 510(k) Clearance Reinforcing Comprehensive Portfolio Supporting Pediatric, Adolescent and Adult Spinal Deformity Patients
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it has received FDA 510(k) clearance for the Company's market-leading...
Sep 12, 2016 04:05 pm ET
NuVasive Names Jason M. Hannon President and Chief Operating Officer; Patrick S. Miles Assumes Role of Vice Chairman
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced Jason M. Hannon has been promoted to president and chief operating...
Sep 06, 2016 07:00 am ET
NuVasive's MAGEC System Featured in Live Surgery Event at the Spine Hospital at NewYork-Presbyterian
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced a key event in the Company's advancement in the treatment of patients...
Sep 02, 2016 07:00 am ET
NuVasive to Participate in Investor Events in September 2016
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will participate in the following investor events in...
Aug 04, 2016 07:00 am ET
NuVasive Secures CMS Add-On Payment for Innovative MAGEC System
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has...
Aug 01, 2016 07:00 am ET
Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Mike O'Halleran and Pat Miles to the Company's...
Jul 26, 2016 04:02 pm ET
NuVasive Reports Second Quarter 2016 Financial Results
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today financial results for the quarter ended June 30, 2016. Second Quarter...
Jul 12, 2016 07:00 am ET
NuVasive to Feature Industry-Leading Portfolio at 23rd International Meeting on Advanced Spine Technologies
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will participate at the 23rd International Meeting on Advanced...
Jul 05, 2016 07:00 am ET
NuVasive Completes Acquistion of Biotronic NeuroNetwork
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery, today announced that it has successfully completed the previously announced acquisition of Biotronic NeuroNetwork ("Biotronic"), a provider of...
Jun 30, 2016 04:05 pm ET
NuVasive Agrees to Settle Patent Litigation With Medtronic
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery, today announced that the Company has agreed to settle its ongoing patent litigation with Medtronic and certain of its subsidiaries. NuVasive and...
Jun 29, 2016 04:05 pm ET
NuVasive Announces Conference Call and Webcast of Second Quarter 2016 Results
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery, announced today that its second quarter 2016 earnings announcement will take place on Tuesday, July 26, 2016 after the close of the...
Jun 06, 2016 04:05 pm ET
NuVasive to Acquire Biotronic NeuroNetwork
Enhances NuVasive's Spine Service Line Partnership OfferingsDoubles Size of NuVasive's Service Platform with Complementary Geographic FootprintExpanded Platform Drives Greater Utilization and Integration of NuVasive's Procedurally-Integrated...
May 31, 2016 07:00 am ET
NuVasive to Participate in Investor Events in June 2016
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will participate in the following investor events in...
May 23, 2016 07:00 am ET
NuVasive Launches Next Generation Biologics Technology
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the U.S. launch of the newest solution in its biologics portfolio,...
May 13, 2016 07:00 am ET
NuVasive to Feature Game-Changing, Integrated Spine Solutions at SpineWeek 2016
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will exhibit more than 20 surgical solutions at SpineWeek 2016,...
May 05, 2016 04:05 pm ET
NuVasive to Participate in Investor Event in May 2016
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will participate in the following investor event in...
Apr 28, 2016 07:00 am ET
NuVasive Extends Spine Innovator Leadership Position, Launches New Solutions at 84th AANS Annual Scientific Meeting
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will launch five new surgical solutions at the 84th American...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.